X0306
4
2017-10-05
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
Chairman & CEO
Common Stock
2017-10-05
4
M
0
1256
30.75
A
2325
D
Common Stock
2017-10-05
4
M
0
920
30.75
A
676152
I
By Trusts
Common Stock
2017-10-05
4
S
0
200
121.94
D
2125
D
Common Stock
2017-10-05
4
S
0
856
123.0522
D
1269
D
Common Stock
2017-10-05
4
S
0
200
123.69
D
1069
D
Stock Options
30.75
2017-10-05
4
M
0
1256
0
D
2009-12-26
2017-12-31
Common Stock
1256
16474
D
Stock Options
30.75
2017-10-05
4
M
0
920
0
D
2009-12-26
2017-12-31
Common Stock
920
15554
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. The transaction was structured as a broker-assisted cashless exercise, such that the number of shares sold was limited to a sufficient number to cover the exercise price of the options and anticipated taxes. The remaining shares are held by a trust beneficially owned by the reporting person.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $121.49 to $122.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $122.56 to $123.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $123.66 to $123.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2017-10-05